Lysosomal Acid Lipase Market Revenue to outshine USD 1038.08 million By 2027
Posted On June 22, 2021
The Global Lysosomal Acid Lipase Market revenue is anticipated to grow to around USD 1038.08 million by 2027 with a CAGR of 11% during the year 2021-2027 as per the report published by Value Market Research. Increasing demand for enzyme replacement therapy among the patients is the primitive market driver of the growth of the lysosomal acid lipase market. Also, the increasing unfulfilled needs and the use of supportive care therapies are one of the major drivers responsible for the market growth of lysosomal acid lipase. Rising lysosomal acid lipase deficiency cases and the high demand for the treatment will further support the market growth of the lysosomal acid lipase market. However, the high cost of treatment for such diseases and lack of awareness are some of the factors responsible for hampering the market growth of lysosomal acid lipase. High investment for research and development in the medical field will spur the market growth of this market.
An enzyme present in the mammal body that breaks the lipids such as cholesteryl esters and triglycerides present in the cells is known as lysosomal acid lipase. The deficiency of lysosomal acid lipase enzyme leads to fat accumulation in organs and tissues that leads to liver and cardiovascular diseases. And the accumulation of fat in the walls of the gut may lead to serious digestive problems including malabsorption.at PH 4 to PH 5, Lysosomal acid lipase has optimum activity. Wolman disease and cholesteryl ester storage disease are found in humans and are caused due to deficiency of lysosomal acid lipase.
The elaborate study "Global Lysosomal Acid Lipase Market Report By Indication (Wolman Disease (WD), Cholesteryl Ester Storage Disease (CESD), By Treatment Class (Enzyme Replacement Therapy, Lipid-Modifying Agents (Statins), Surgery (Liver Transplant), Stem Cell Transplantation, Supportive Care) And By Regions - Industry Trends, Size, Share, Growth, Estimation And Forecast, 2021-2027" poses a refreshing view of the market taking into consideration all the aspects affecting the market.
On the basis of indication the market is segmented into Wolman Disease (WD), Cholesteryl Ester Storage Disease (CESD). By treatment class the lysosomal acid lipase market is categorised as Enzyme Replacement Therapy, Lipid-Modifying Agents (Statins), Surgery (Liver Transplant), Stem Cell Transplantation, Supportive Care.The report covers North America (North America, United State and Rest of North America), Europe (United Kingdom, France , Germany, Rest of Europe), Asia Pacific (China, Japan, India, Rest of Asia Pacific), Latin America (Brazil, Rest of Latin America) and Middle East & Africa. The data tables in these chapters give the market estimates on the basis of all the segments.
The Report Segments Global Lysosomal Acid Lipase Market -
- Wolman Disease (WD)
- Cholesteryl Ester Storage Disease (CESD)
By Treatment Class
- Enzyme Replacement Therapy
- Lipid-Modifying Agents (Statins)
- Surgery (Liver Transplant)
- Stem Cell Transplantation
- Supportive Care
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
Players Profiled In the Report:
AstraZeneca plc., Alexion Pharmaceutical Inc., Pfizer, Merck & Co., Inc., Pfizer, Inc., and Teva Pharmaceutical Industries Ltd.
Download the FREE SAMPLE of Global Lysosomal Acid Lipase Market Research Report
About Value Market Research -
Value Market Research was established with the vision to ease decision making and empower the strategists by providing them with holistic market information. Our analysts’ team is well equipped with all research tools and techniques and hold deep knowledge of the industry they are working for.
We ensure intellectual, precise and quality data is delivered to our client. We facilitate clients with syndicate research reports and customized research reports on 25+ industries with global as well as regional coverage.
Value Market Research
401/402, TFM, Nagras Road, Aundh, Pune-7.
Email: [email protected]